Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sexuality × exemestane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 171 Neoplasm Metastasis 16 Neoplasms 6 Breast Neoplasms, Male 6 Ovarian Neoplasms 4 Breast Diseases 4 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Breast Cancer Metastatic 3 Prostatic Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bulbo-Spinal Atrophy, X-Linked 2 Advanced Breast Cancer 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Skin Diseases 1 Sexuality 1 Recurrence 1 Primary Breast Cancer ER+ve 1 Premenopausal Breast Cancer 1 Pancreatic Neoplasms 1 Obesity 1 Neuroendocrine Tumors 1 Neoplasms by Site 1 Multiple Endocrine Neoplasia Type 1 1

Interventions

Psychiatric Rehabilitation 3 Counseling 3 exemestane 1 black cohosh root extract 1 Testosterone Propionate 1 Testosterone 1 Tamoxifen 1 Surveys and Questionnaires 1 Sildenafil Citrate 1 Sexual Health 1 Radiotherapy 1 Pilocarpine 1 Oncology Nursing 1 Educational Status 1 Aromatase Inhibitors 1 Arginine 1 ArginMax 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02467686 2017-03-20

Cimicifuga

Irmandade da Santa Casa de Misericordia de Sao Paulo

Phase 4 Unknown

Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon ⚡